CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($) shares in Thousands, $ in Thousands	3 Months Ended
	Mar. 31, 2024	Mar. 31, 2023
Revenue:
Revenues	$ 93,855	$ 80,951
Expenses:
Cost of sales	59,209	34,086
Research and development	92,679	247,101
Selling, general, and administrative	86,798	112,532
Total expenses	238,686	393,719
Loss from operations	(144,831)	(312,768)
Other income (expense):
Interest expense	(4,111)	(4,316)
Other income	3,654	24,362
Loss before income taxes	(145,288)	(292,722)
Income tax expense	2,262	1,183
Net loss	$ (147,550)	$ (293,905)
Net loss per share:
Basic (in usd per share)	$ (1.05)	$ (3.41)
Diluted (in usd per share)	$ (1.05)	$ (3.41)
​Weighted average number of common shares outstanding:
Basic (in shares)	139,916	86,158
Diluted (in shares)	139,916	86,158
Product sales
Revenue:
Revenues	$ 82,324	$ (7,457)
Grants
Revenue:
Revenues	0	87,379
Royalties and other
Revenue:
Revenues	$ 11,531	$ 1,029